Pheonix Research Publishes 2026 “Global Point-of-Care Testing (POCT) Market Outlook – Press Release”

Global Point-of-Care Testing (POCT) Market to Reach USD 89.66 Billion by 2033, Driven by Rapid Diagnostics and Decentralized Healthcare

March 2026 | Pheonix Research

The Global Point-of-Care Testing (POCT) Market is projected to grow from USD 48.60 billion in 2025 to USD 89.66 billion by 2033, expanding at a CAGR of 7.96% during the forecast period, according to the latest analysis by Pheonix Research.

The market growth is driven by the increasing demand for rapid and accessible diagnostic solutions, rising adoption of decentralized healthcare models, and advancements in diagnostic technologies such as biosensors and molecular testing. The ability to deliver real-time results at or near patient care settings is significantly improving clinical decision-making and patient outcomes.

Shakshi Dubey, Analyst – Healthcare & Medical Devices at Pheonix Research, stated:
“The POCT market is transforming healthcare delivery by enabling faster, more accessible diagnostics. The shift toward decentralized care, combined with advancements in molecular diagnostics and biosensor technologies, will be key growth drivers in the coming years.”

Key Market Highlights:

• Regional Insights:
  • North America: Largest market supported by advanced healthcare infrastructure, strong reimbursement policies, and high adoption of rapid diagnostic technologies.
  • Asia-Pacific: Fastest-growing region driven by expanding healthcare access, rising chronic disease burden, and growing demand in China and India.
  • Europe: Growth driven by technological integration and regulatory support for advanced diagnostic solutions.
  • Latin America & MEA: Emerging markets benefiting from increasing healthcare investments and demand for cost-effective diagnostic tools.
• Product and Application Trends:
  • Infectious disease testing: Rapid diagnostics for COVID-19, influenza, and other infections.
  • Cardiometabolic testing: Blood glucose and cholesterol monitoring for chronic disease management.
  • Pregnancy & fertility testing: Increasing demand for home-based diagnostic solutions.
  • Molecular diagnostics & biosensors: Enhancing accuracy and speed of POCT devices.
• Competitive Landscape:
  • Abbott Laboratories: Strong portfolio in rapid diagnostics and global market presence.
  • Medtronic: Advanced medical device integration and innovation capabilities.
  • Amedisys: Expansion in home-based and decentralized healthcare solutions.
  • Emerging players: Focus on AI-enabled diagnostics and portable testing devices.
• Market Drivers:
  • Innovation & Commercialization: Advancements in biosensors, molecular testing, and next-generation diagnostic platforms.
  • Regulatory Compliance: Evolving FDA and global standards shaping product development and approvals.
  • Capital & Capacity Scaling: Investments in healthcare technology and expansion of diagnostic infrastructure.

The market is further supported by the growing trend of home-based testing, increasing adoption of digital health platforms, and rising need for efficient and cost-effective diagnostic solutions, reinforcing long-term growth potential.

Pheonix Research’s latest report provides in-depth insights into market trends, regional dynamics, competitive benchmarking, and long-term growth opportunities across the Global Point-of-Care Testing (POCT) Market.

📈 For a detailed look at the full report, visit:
👉https://www.pheonixresearch.com/healthcare/medical-devices/market-report/global-point-of-care-testing-poct-market/

About Pheonix Research

Pheonix Research is a global market intelligence and strategic advisory firm delivering data-driven insights across healthcare, medical devices, and other high-growth sectors. Through advanced forecasting tools and AI-backed analytics, the firm supports stakeholders in identifying emerging opportunities and achieving sustainable competitive advantage.

Media Contact:

Pheonix Research
Email: Media@pheonixresearch.com
Website: www.pheonixresearch.com